Please Wait...

ClinPlan

Budget Management and Cash Forecasting for Clinical Trials

ClinPlan significantly reduces the time to generate a forecast, improves forecast accuracy, and easily identifies delays and expense increases by trial phase. With ClinPlan, sponsors and CROs can efficiently and frequently assess trial expense needs based on activities, such as site and subject enrollment, in order to proactively plan for funds necessary to support the needed ongoing expenses of a clinical trial. This automation fosters collaborative, more accurate financial reporting, reduces the variance between budgeted and actual expense views, to help speed valuable new drug products to market.

With ClinPlan, sponsors and CROs benefit from:

Consolidated Budgets

Consolidated Budgets

  • Store and maintain budgets in one location from a variety of vendors and sources that contribute to total trial expense
  • Reduce time operations staff spend on analyzing individual vendor budget spreadsheets to manage the total trial budget

 

Reduction in Variance

Reduction in Variance

  • Reforecast trial expenses regularly by importing real-time data, resulting in proactive decision-making and reduction in variance between budgeted and actual budgets
  • Strengthen sponsor-CRO relationships and retain high-enrolling, high-performing sites for your studies

 

Improved Cash Management

Improved Cash Management

  • Import global expense profiles for participating geographic regions, site activation/enrollment data, and expected schedule of assessment profiles and related expenses
  • Evaluate and reevaluate costs using actual trial data once operational activity begins, to show how the status of the study impacts the funds necessary, preventing under or over-requesting for funds

Download our ClinPlan Data Sheet

ADDITIONAL RESOURCES

Bioclinica Financial Lifecycle Solutions Platform

Download Overview SHEET

6 Reasons Why You Should Choose Bioclinica's Financial Lifecycle Solutions

Download Infographic

Streamline Clinical Trial Financial Lifecycles with Bioclinica's ClinPlan + ClinPay Integration

Download Infographic

Challenges with Cash Management and Reforecasting Clinical Trials

Download eBook

ROI Initiative: A Technology Solution for Investigator Payments

Download eBook

Budget Management & Forecasting for Clinical Trials

Download eBook

Embracing Clinical Trial Technology

Download eBook

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (13 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (13 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (13 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (13 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (13 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (14 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices